Attached files
| file | filename |
|---|---|
| EX-31.2 - PROVECTUS BIOPHARMACEUTICALS, INC. | ex31-2.htm |
| EX-31.1 - PROVECTUS BIOPHARMACEUTICALS, INC. | ex31-1.htm |
| 10-Q - PROVECTUS BIOPHARMACEUTICALS, INC. | form10-q.htm |
Exhibit 32
CERTIFICATION PURSUANT TO RULE 13a-14(b) UNDER
THE SECURITIES EXCHANGE ACT OF 1934 AND
SECTION 1350 OF CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE
Each of the undersigned, Bruce Horowitz, the Chief Operating Officer (principal executive officer) of Provectus Biopharmaceuticals, Inc. (the “Company”), and Heather Raines, CPA, the Chief Financial Officer (principal financial officer) of the Company, certifies, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code, that (1) this Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act, and (2) the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.
This Certification is signed on May 11, 2021.
| By: | /s/ Bruce Horowitz | |
| Bruce Horowitz | ||
| Chief Operating Officer (Principal Executive Officer) |
| By: | /s/ Heather Raines | |
| Heather Raines, CPA | ||
| Chief Financial Officer (Principal Financial Officer) |